Kashiv BioSciences Secures $150 Million Debt Financing from GoldenTree Asset Management
PISCATAWAY, N.J.–(BUSINESS WIRE)–Kashiv BioSciences, LLC (“Kashiv BioSciences” or the “Company”), a fully integrated biopharmaceutical company, today announced that it has entered into a senior secured credit agreement with GoldenTree Asset Management (“GoldenTree”) as the sole…
